Parallax Volatility Advisers
IBB icon

Parallax Volatility Advisers’s iShares Biotechnology ETF IBB Stock Holding History

Parallax Volatility Advisers’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,526
Closed -$2.28M – 1671
2025
Q4 		$2.28M Buy
+13,526
New +$2.2M ﹤0.01% 908
2025
Q3 		– Sell
-19,416
Closed -$2.46M – 1705
2025
Q2 		$2.46M Buy
19,416
+19,413
+647,100% +$2.38M 0.01% 820
2025
Q1 		$384 Sell
3
-62,284
-100% -$8.45M ﹤0.01% 1474
2024
Q4 		$8.23M Buy
62,287
+62,284
+2,076,133% +$8.76M 0.02% 634
2024
Q3 		$437 Hold
3
– – ﹤0.01% 1973
2024
Q2 		$412 Hold
3
– – ﹤0.01% 1930
2024
Q1 		$412 Hold
3
– – ﹤0.01% 1750
2023
Q4 		$408 Buy
+3
New +$366 ﹤0.01% 2103
2023
Q3 		– Sell
-3
Closed -$381 – 2426
2023
Q2 		$381 Hold
3
– – ﹤0.01% 2305
2023
Q1 		$387 Hold
3
– – ﹤0.01% 2621
2022
Q4 		$394 Hold
3
– – ﹤0.01% 2771
2022
Q3 		$0 Sell
3
-13,774
-100% -$1.71M ﹤0.01% 3214
2022
Q2 		$1.62M Buy
13,777
+13,774
+459,133% +$1.64M ﹤0.01% 1440
2022
Q1 		$0 Hold
3
– – ﹤0.01% 2917
2021
Q4 		$0 Sell
3
-30,850
-100% -$4.78M ﹤0.01% 2086
2021
Q3 		$4.99M Buy
+30,853
New +$5.19M ﹤0.01% 837
2021
Q1 		– Sell
-194,359
Closed -$29.4M – 1563
2020
Q4 		$29.4M Buy
194,359
+82,959
+74% +$11.9M 0.03% 425
2020
Q3 		$15.1M Buy
111,400
+42,869
+63% +$5.82M 0.01% 823
2020
Q2 		$9.37M Buy
68,531
+63,567
+1,281% +$8.1M 0.01% 818
2020
Q1 		$535K Sell
4,964
-72,009
-94% -$8.29M ﹤0.01% 1703
2019
Q4 		$9.28M Buy
76,973
+71,118
+1,215% +$7.93M 0.01% 681
2019
Q3 		$583K Sell
5,855
-48,215
-89% -$5.05M ﹤0.01% 1564
2019
Q2 		$5.9M Buy
54,070
+11,068
+26% +$1.18M 0.01% 669
2019
Q1 		$4.81M Buy
43,002
+14,958
+53% +$1.64M 0.01% 705
2018
Q4 		$2.7M Buy
28,044
+28,041
+934,700% +$2.98M ﹤0.01% 942
2018
Q3 		$0 Hold
3
– – ﹤0.01% 3013
2018
Q2 		$0 Hold
3
– – ﹤0.01% 2640
2018
Q1 		$0 Hold
3
– – ﹤0.01% 3148
2017
Q4 		$0 Hold
3
– – ﹤0.01% 4370
2017
Q3 		$0 Hold
3
– – ﹤0.01% 2594
2017
Q2 		$0 Hold
3
– – ﹤0.01% 3000
2017
Q1 		$0 Hold
3
– – ﹤0.01% 4029
2016
Q4 		$0 Hold
3
– – ﹤0.01% 3521
2016
Q3 		$0 Hold
3
– – ﹤0.01% 3329
2016
Q2 		$0 Hold
3
– – ﹤0.01% 2947
2016
Q1 		$0 Sell
3
-149,805
-100% -$13.4M ﹤0.01% 3015
2015
Q4 		$16.9M Buy
149,808
+149,805
+4,993,500% +$16.3M 0.03% 321
2015
Q3 		$0 Sell
3
-198
-99% -$23.7K ﹤0.01% 3405
2015
Q2 		$25K Buy
201
+198
+6,600% +$23.7K ﹤0.01% 2828
2015
Q1 		$0 Hold
3
– – ﹤0.01% 4849
2014
Q4 		$0 Sell
3
-47,850
-100% -$4.65M ﹤0.01% 5379
2014
Q3 		$4.37M Sell
47,853
-142,104
-75% -$12.5M 0.01% 769
2014
Q2 		$16.3M Buy
+189,957
New +$15M 0.07% 214

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parallax Volatility Advisers's IBB Position: Q1 2026 in Review

Parallax Volatility Advisers sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 13,526 shares — an estimated $2.28M sold.

Parallax Volatility Advisers first reported a position in IBB in Q2 2014 and held it in 43 quarters. The position peaked at $29.4M in Q4 2020. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Parallax Volatility Advisers reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • Parallax Volatility Advisers sold 13,526 iShares Biotechnology ETF shares in Q1 2026, an estimated $2.28M.
  • Parallax Volatility Advisers first reported a position in iShares Biotechnology ETF in Q2 2014 and held it in 43 quarters.
  • Parallax Volatility Advisers's iShares Biotechnology ETF position peaked at $29.4M in Q4 2020.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.